WeightWatchers and Novo Nordisk Expand Partnership to Improve Wegovy Access
WeightWatchers expands its partnership with Novo Nordisk to improve access to FDA-approved Wegovy for weight loss. The collaboration includes a limited-time price of $299, integrated pharmacy fulfillment, and a commitment to real-world research combining GLP-1 treatment with lifestyle support.
WeightWatchers Files for Bankruptcy Amid Ozempic Era, Focuses on Telehealth
WeightWatchers files for bankruptcy to eliminate $1.15B in debt as it shifts focus to telehealth amid growing demand for weight-loss drugs like Ozempic.
Leadership Shakeup at WeightWatchers: Sima Sistani Departs, Tara Comonte Appointed Interim CEO
WeightWatchers announces the immediate departure of CEO Sima Sistani, with board member Tara Comonte stepping in as Interim CEO. The leadership change comes as the company focuses on improving operational and financial performance amid recent challenges.